Conference Coverage
Conference Coverage
Magnesium disappoints in sickle cell disease
sickle cell disease Credit: St.
Conference Coverage
Product controls bleeding in kids with hemophilia A
the 2014 ASH Annual Meeting SAN FRANCISCO—A recombinant factor VIII (FVIII) Fc fusion protein is effective for routine prophylaxis and control of...
Conference Coverage
Two activin receptor fusion proteins show promise in anemia
site of the ASH Annual Meeting Photo courtesy of ASH SAN FRANCISCO—Two activin receptor fusion proteins, luspatercept and sotatercept, increased...
Conference Coverage
Ixazomib induces durable responses in hard-to-treat amyloidosis
Photo courtesy of ASH SAN FRANCISCO—The oral proteasome inhibitor ixazomib induces high-quality hematologic responses in patients with relapsed/...
Conference Coverage
First randomized evidence for kinase inhibitor use in AML
Photo courtesy of ASH SAN FRANCISCO—Researchers have presented the first randomized evidence that kinase inhibitors are effective in the...
Conference Coverage
Antibody shows activity in relapsed/refractory NHL
“It is encouraging to see results in an NHL study that selects a different target than CD20,” said Kristie Blum, MD, of The Ohio State University...
Conference Coverage
Combo may enhance spleen reductions in MF
the 2014 ASH Annual Meeting SAN FRANCISCO—Combination therapy with ruxolitinib and panobinostat shows signs of efficacy in myelofibrosis (MF),...
Conference Coverage
Hopkins protocol aims to limit sarcoma morcellation risk
Key clinical point: In addition to the FDA’s recent morcellation contraindications, the procedure shouldn’t be done in women who have uterine...
Conference Coverage
More isn’t always better with daunorubicin induction in AML
Photo courtesy of ASH SAN FRANCISCO—Results regarding daunorubicin escalation in induction for patients with acute myeloid leukemia (AML) have...
Conference Coverage
CLL drug can fight AML too, study suggests
Credit: FDA SAN FRANCISCO—A BCL2 inhibitor that previously proved active against chronic lymphocytic leukemia has shown activity in certain...
Conference Coverage
Investigational sotatercept improves heme parameters in MDS
Key clinical point: Sotatercept is a first-in-its-class agent that stimulates erythropoiesis through a mechanism different from that of...